Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling

Cell-based gene therapy has become a subject of interest for the treatment of pulmonary arterial hypertension (PAH), a devastating disease characterized by pulmonary artery smooth muscle cell (PASMC) hyperplasia. Mesenchymal stem cells (MSCs) have been recently acknowledged as a potential cell vecto...

Full description

Saved in:
Bibliographic Details
Published inStem cell research & therapy Vol. 8; no. 1; p. 34
Main Authors Cheng, Gesheng, Wang, Xingye, Li, Yongxin, He, Lu
Format Journal Article
LanguageEnglish
Published England BioMed Central 10.02.2017
Subjects
Online AccessGet full text
ISSN1757-6512
1757-6512
DOI10.1186/s13287-017-0480-y

Cover

Loading…